Lack of effect of sildenafil on cocaine-induced convulsions in mice

Pharmacological Reports

Volumn 61, Issue 5, 2009, Pages 930-934

  Nieoczym, Dorota ^a   Socała, Katarzyna ^a   Wlaź, Piotr ^a  

^a MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

Author keywords

Clonus; Cocaine; Convulsions; Mice; Sildenafil

Indexed keywords

COCAINE; SILDENAFIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG TREATMENT FAILURE; LATENT PERIOD; MALE; MOUSE; NONHUMAN;

EID: 70549100027     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(09)70151-3     Document Type: Article

References (36)

1. Ahern GP, Klyachko VA, Jackson MB: cGMP and S-nitrosylation: two routes for modulation of neuronal excitability by NO. Trends Neurosci, 2002, 25, 510-517.
2. Akula KK, Dhir A, Kulkarni SK: Nitric oxide signaling pathway in the anti-convulsant effect of adenosine against pentylenetetrazol-induced seizure threshold in mice. Eur J Pharmacol, 2008, 587, 129-134.
3. Aldridge J, Measham F: Sildenafil (Viagra) is used as a recreational drug in England. BMJ, 1999, 318, 669-669
4. Ambriz-Tututi M, Velazquez-Zamora DA, Urquiza-Marin H, Granados-Soto V: Analysis of the mechanism underlying the peripheral antinociceptive action of sildenafil in the formalin test. Eur J Pharmacol, 2005, 512, 121-127. (Pubitemid 40544345)
5. Bezerra MM, Lima V, Girao VC, Teixeira RC, Graca JR: Antinociceptive activity of sildenafil and adrenergic agents in the writhing test in mice. Pharmacol Rep, 2008, 60, 339-344.
6. Boghdadi MS, Henning RJ: Cocaine: pathophysiology and clinical toxicology. Heart Lung, 1997, 26, 466-483.
7. Boissier J-R, Tardy J, Diverres J-C: Une nouvelle methode simple pour explorer l'action 'tranquillisante': le test de la cheminee. Med Exp, 1960, 3, 81-84.
8. Brackett RL, Pouw B, Blyden JF, Nour M, Matsumoto RR: Prevention of cocaine-induced convulsions and lethality in mice: effectiveness of targeting different sites on the NMDA receptor complex. Neuropharmacology, 2000, 39, 407-418. (Pubitemid 30052930)
9. Brown E, Prager J, Lee HY, Ramsey RG: CNS complications of cocaine abuse: prevalence, pathophysiology, and neuroradiology. AJR Am J Roentgenol, 1992, 159, 137-147.
10. Devan BD, Bowker JL, Duffy KB, Bharati IS, Jimenez M, Sierra-Mercado D, Jr., Nelson CM et al.: Phosphodiesterase inhibition by sildenafil citrate attenuates a maze learning impairment in rats induced by nitric oxide synthase inhibition. Psychopharmacology (Berl), 2006, 183, 439-445. (Pubitemid 41721145)
11. Ferrari F, Ottani A, Giuliani D: Influence of sildenafil on central dopamine-mediated behaviour in male rats. Life Sci, 2002, 70, 1501-1508. (Pubitemid 34164544)
12. B receptors affects cocaine-induced seizures in mice. Psychopharmacology (Berl), 2004, 174, 211-219. (Pubitemid 38916294)
13. Gasior M, Ungard JT, Witkin JM: Chlormethiazole: effectiveness against toxic effects of cocaine in mice. J Pharmacol Exp Ther, 2000, 295, 153-161. (Pubitemid 30746075)
14. Gilad R, Lampl Y, Eshel Y, Sadeh M: Tonic-clonic seizures in patients taking sildenafil. BMJ, 2002, 325, 869-869
15. Hotchkiss AK, Pyter LM, Gatien ML, Wen JC, Milman HA, Nelson RJ: Aggressive behavior increases after termination of chronic sildenafil treatment in mice. Physiol Behav, 2005, 83, 683-688.
16. Itzhak Y: Attenuation of cocaine kindling by 7-nitroindazole, an inhibitor of brain nitric oxide synthase. Neuropharmacology, 1996, 35, 1065-1073. (Pubitemid 27008181)
17. Itzhak Y: Nitric oxide (NO) synthase inhibitors abolish cocaine-induced toxicity in mice. Neuropharmacology, 1993, 32, 1069-1070. (Pubitemid 23316514)
18. Kurt M, Bilge SS, Aksoz E, Kukula O, Celik S, Kesim Y: Effect of sildenafil on anxiety in the plus-maze test in mice. Pol J Pharmacol, 2004, 56, 353-357. (Pubitemid 39010771)
19. Lason W: Neurochemical and pharmacological aspects of cocaine-induced seizures. Pol J Pharmacol, 2001, 53, 57-60. (Pubitemid 32288338)
20. Matsumoto RR, Brackett RL, Kanthasamy AG: Novel NMDA/glycine site antagonists attenuate cocaine-induced behavioral toxicity. Eur J Pharmacol, 1997, 338, 233-242.
21. Milman HA, Arnold SB: Neurologic, psychological, and aggressive disturbances with sildenafil. Ann Pharmacother, 2002, 36, 1129-1134.
22. Park K, Vora U, Darling SF, Kolta MG, Soliman KF: The role of inducible nitric oxide synthase in cocaine-induced locomotor sensitization. Physiol Behav, 2001, 74, 441-447. (Pubitemid 34076589)
23. Park KK, Reuben JS, Soliman KF: The role of inducible-nitric oxide in cocaine-induced kindling. Exp Biol Med, 2001, 226, 185-190.
24. Patil CS, Singh VP, Kulkarni SK: Modulatory effect of sildenafil in diabetes and electroconvulsive shock-induced cognitive dysfunction in rats. Pharmacol Rep, 2006, 58, 373-380.
25. Paul V, Ekambaram P: Effects of sodium nitroprusside, a nitric oxide donor, on γ-aminobutyric acid concentra- tion in the brain and on picrotoxin-induced convulsions in combination with phenobarbitone in rats. Pharmacol Biochem Behav, 2005, 80, 363-370. (Pubitemid 40299336)
26. Prast H, Philippu A: Nitric oxide as modulator of neuronal function. Prog Neurobiol, 2001, 64, 51-68. (Pubitemid 32201889)
27. Prickaerts J, Sik A, van Staveren WC, Koopmans G, Steinbusch HW, van der Staay FJ, de Vente J, Blokland A: Phosphodiesterase type 5 inhibition improves early memory consolidation of object information. Neurochem Int, 2004, 45, 915-928.
28. Rajasekaran K, Jayakumar R, Venkatachalam K: Increased neuronal nitric oxide synthase (nNOS) activity triggers picrotoxin-induced seizures in rats and evidence for participation of nNOS mechanism in the action of antiepileptic drugs. Brain Res, 2003, 979, 85-97. (Pubitemid 36792159)
29. Riazi K, Roshanpour M, Rafiei-Tabatabaei N, Homayoun H, Ebrahimi F, Dehpour AR: The proconvulsant effect of sildenafil in mice: role of nitric oxide-cGMP pathway. Br J Pharmacol, 2006, 147, 935-943.
30. Rundfeldt C, Koch R, Richter A, Mevissen M, Gerecke U, Löscher W: Dose-dependent anticonvulsant and proconvulsant effects of nitric oxide synthase inhibitors on seizure threshold in a cortical stimulation model in rats. Eur J Pharmacol, 1995, 274, 73-81.
31. Shimosato K, Watanabe S, Katsura M, Ohkuma S: Role of cerebral spermidine in the development of sensitization to convulsant activity of cocaine and lidocaine. Brain Res, 1997, 775, 198-202. (Pubitemid 28020505)
32. G-nitro-L-arginine differentially affects glutamate- or kainate-induced seizures. Neuroreport, 1996, 7, 1605-1608.
33. Uthayathas S, Karuppagounder SS, Tamer SI, Parameshwaran K, Degim T, Suppiramaniam V, Dhanasekaran M: Evaluation of neuroprotective and anti-fatigue effects of sildenafil. Life Sci, 2007, 81, 988-992.
34. Uthayathas S, Karuppagounder SS, Thrash BM, Parameshwaran K, Suppiramaniam V, Dhanasekaran M: Versatile effects of sildenafil: recent pharmacological applications. Pharmacol Rep, 2007, 59, 150-163. (Pubitemid 46952406)
35. A current of hippocampal neurons. Brain Res, 1997, 770, 169-175. (Pubitemid 27468064)
36. Zhu CB, Hewlett WA, Francis SH, Corbin JD, Blakely RD: Stimulation of serotonin transport by the cyclic GMP phosphodiesterase-5 inhibitor sildenafil. Eur J Pharmacol, 2004, 504, 1-6.